118 related articles for article (PubMed ID: 7015615)
1. Circulating immune complexes in pediatric renal allograft rejection.
Jordan SC; Sakai R; Malekzadeh MH; Pennisi AJ; Ettenger RB; Uittenbogaart CH; Fine RN
Transplantation; 1981 Mar; 31(3):190-4. PubMed ID: 7015615
[TBL] [Abstract][Full Text] [Related]
2. Circulating immune complexes during various forms of renal allograft rejection episodes.
Jordan SC; Sakai R; Ettenger RB; Fine RN
Nephron; 1982; 31(2):141-5. PubMed ID: 6750420
[TBL] [Abstract][Full Text] [Related]
3. Evaluation and clinical significance of circulating immune complexes after renal transplantation.
Fukuda M
Transplantation; 1983 Aug; 36(2):155-60. PubMed ID: 6349040
[TBL] [Abstract][Full Text] [Related]
4. Circulating immune complexes after renal transplantation. Correlation of increased 125I-Clq binding activity with acute rejection characterized by fibrin deposition in the kidney.
Ooi YM; Ooi BS; Vallota EH; First MR; Pollak VE
J Clin Invest; 1977 Sep; 60(3):611-9. PubMed ID: 330564
[TBL] [Abstract][Full Text] [Related]
5. Serial study of circulating immune complexes before and after renal transplantation.
Johny KV; Dasgupta MK; Kovithavongs T; Dossetor JB
Kidney Int; 1981 Feb; 19(2):332-40. PubMed ID: 7014986
[TBL] [Abstract][Full Text] [Related]
6. Circulating immune complexes in renal transplant patients.
Sølling J
Clin Nephrol; 1983 Jan; 19(1):11-6. PubMed ID: 6339128
[TBL] [Abstract][Full Text] [Related]
7. Comparison of different assays for circulating immune complexes in age matched vasectomized and non-vasectomized men.
Witkin SS; Brandslund I; Svehag SE; Linnet L; møller NP
J Clin Lab Immunol; 1983 Apr; 10(4):193-7. PubMed ID: 6602887
[TBL] [Abstract][Full Text] [Related]
8. [Circulating immune complexes before and after kidney allotransplantation].
Keusch G; Vonwiller HM; von Felten A; Bammatter F; Burger HR; Largiadèr F; Binswanger U
Klin Wochenschr; 1984 Apr; 62(8):360-5. PubMed ID: 6374279
[TBL] [Abstract][Full Text] [Related]
9. A new C1q solid-phase assay for the detection of IgM immune complexes: application to the follow-up of kidney graft recipients with recurrent cytomegalovirus infection.
Basson J; Tardy JC; Aymard M
J Clin Lab Immunol; 1990 Jan; 31(1):43-9. PubMed ID: 1966984
[TBL] [Abstract][Full Text] [Related]
10. Correlation of clinical outcomes after tacrolimus conversion for resistant kidney rejection or cyclosporine toxicity with pathologic staging by the Banff criteria.
Morrissey PE; Gohh R; Shaffer D; Crosson A; Madras PN; Sahyoun AI; Monaco AP
Transplantation; 1997 Mar; 63(6):845-8. PubMed ID: 9089224
[TBL] [Abstract][Full Text] [Related]
11. Immune complexome analysis of antigens in circulating immune complexes from patients with acute cellular rejection after living donor liver transplantation.
Aibara N; Ohyama K; Hidaka M; Kishikawa N; Miyata Y; Takatsuki M; Eguchi S; Kuroda N
Transpl Immunol; 2018 Jun; 48():60-64. PubMed ID: 29477751
[TBL] [Abstract][Full Text] [Related]
12. Preoperative single-bolus high-dose antithymocyte globulin as induction therapy in sensitized renal transplant recipients.
Wang D; Wu WZ; Yang SL; Chen JH; Tan JM
Chin Med J (Engl); 2006 Oct; 119(20):1683-8. PubMed ID: 17097014
[TBL] [Abstract][Full Text] [Related]
13. Serial analysis of circulating immune complexes, complement, and antithymocyte globulin antibodies in heart transplant recipients.
Harkiss GD; Brown DL; Cory-Pearce R; English TA
J Clin Immunol; 1983 Apr; 3(2):117-26. PubMed ID: 6343417
[TBL] [Abstract][Full Text] [Related]
14. Alemtuzumab induction therapy in highly sensitized kidney transplant recipients.
Lü TM; Yang SL; Wu WZ; Tan JM
Chin Med J (Engl); 2011 Mar; 124(5):664-8. PubMed ID: 21518554
[TBL] [Abstract][Full Text] [Related]
15. Basiliximab versus antithymocyte globulin for prevention of acute renal allograft rejection.
Sollinger H; Kaplan B; Pescovitz MD; Philosophe B; Roza A; Brayman K; Somberg K
Transplantation; 2001 Dec; 72(12):1915-9. PubMed ID: 11773888
[TBL] [Abstract][Full Text] [Related]
16. A pharmacoeconomic comparison of antithymocyte globulin and muromonab CD3 induction therapy in renal transplant recipients.
Brennan DC; Schnitzler MA; Baty JD; Ceriotti CS; Lowell JA; Shenoy S; Howard TK; Woodward RS
Pharmacoeconomics; 1997 Mar; 11(3):237-45. PubMed ID: 10165313
[TBL] [Abstract][Full Text] [Related]
17. Excellent renal allograft survival in donor-specific antibody positive transplant patients-role of intravenous immunoglobulin and rabbit antithymocyte globulin.
Mai ML; Ahsan N; Wadei HM; Genco PV; Geiger XJ; Willingham DL; Taner CB; Hewitt WR; Grewal HP; Nguyen JH; Hughes CB; Gonwa TA
Transplantation; 2009 Jan; 87(2):227-32. PubMed ID: 19155977
[TBL] [Abstract][Full Text] [Related]
18. Effect of prophylaxis with low-dose anti-thymocyte globulin on prevention of acute kidney allograft rejection.
Khosroshahi HT; Tubbs RS; Shoja MM; Ghafari A; Noshad H; Ardalan MR
Transplant Proc; 2008; 40(1):137-9. PubMed ID: 18261569
[TBL] [Abstract][Full Text] [Related]
19. Preformed donor-specific antibodies and risk of antibody-mediated rejection in repeat renal transplantation.
Tsapepas DS; Vasilescu R; Tanriover B; Coppleson Y; Rekhtman Y; Hardy MA; Dube G; Crew RJ; Ratner LE; Cohen DJ; Mohan S
Transplantation; 2014 Mar; 97(6):642-7. PubMed ID: 24637863
[TBL] [Abstract][Full Text] [Related]
20. An enzyme-linked immunoassay for detection of IgG- and C3-containing circulating immune complexes: comparison with a radioimmunoassay and quantitation in patients with rheumatic diseases.
Panush RS; Somberg LB; Katz P; Longley S
Diagn Immunol; 1983; 1(4):288-94. PubMed ID: 6388973
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
